Related Experiment Videos
Extracorporal low-density lipoprotein elimination by immunoadsorption
1Medizinische Klinik, Klinikum Ibbenbüren, Ibbenbüren, Germany. M.Ritter@Krankenhaus-Ibbenbueren.de
Summary
Low-density lipoprotein (LDL) apheresis helps patients with coronary heart disease when cholesterol goals aren't met. Immunoadsorption, an affinity chromatography method, has unique pros and cons for patient selection.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
Background:
- Coronary heart disease (CHD) management often requires lowering low-density lipoprotein (LDL) cholesterol.
- Some patients with CHD do not reach target LDL cholesterol levels with standard therapies.
- LDL apheresis is an established extracorporeal treatment for severe hypercholesterolemia.
Purpose of the Study:
- To review the therapeutic utility of LDL apheresis in patients with CHD.
- To discuss immunoadsorption as a specific apheresis technique.
- To highlight the advantages and disadvantages of immunoadsorption for patient selection.
Main Methods:
- Review of existing literature on LDL apheresis and immunoadsorption.
- Discussion of the principles of affinity chromatography used in immunoadsorption.
- Analysis of clinical data and guidelines related to apheresis therapy.
Main Results:
- LDL apheresis is effective for patients with CHD unresponsive to conventional lipid-lowering treatments.
- Immunoadsorption, the first commercial apheresis technique, utilizes affinity chromatography.
- The selection of an apheresis method requires careful consideration of individual patient factors, including the specific benefits and drawbacks of immunoadsorption.
Conclusions:
- LDL apheresis offers a valuable therapeutic option for select CHD patients.
- Immunoadsorption is a key technique with distinct characteristics.
- Personalized patient management is crucial when choosing among available apheresis strategies.